Download presentation
Presentation is loading. Please wait.
Published byCecilia Viklund Modified over 6 years ago
1
Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G. Nguyen, Katsuto Shinohara, Matthew R. Cooperberg, Peter R. Carroll European Urology Oncology Volume 1, Issue 5, Pages (October 2018) DOI: /j.euo Copyright © 2018 European Association of Urology Terms and Conditions
2
Fig. 1 CONSORT diagram of patient selection within the prospective study of active surveillance at University of California San Francisco. European Urology Oncology 2018 1, DOI: ( /j.euo ) Copyright © 2018 European Association of Urology Terms and Conditions
3
Fig. 2 Kaplan-Meier curves for reclassification-free survival by Gleason grade 3+3 (n=1119) and 3+4 (n=124) at diagnostic biopsy for the active surveillance cohort at University of California San Francisco. European Urology Oncology 2018 1, DOI: ( /j.euo ) Copyright © 2018 European Association of Urology Terms and Conditions
4
Fig. 3 Kaplan-Meier curves for treatment-free survival by Gleason grade 3+3 (n=1119) and 3+4 (n=124) at diagnostic biopsy for the active surveillance cohort at University of California San Francisco. European Urology Oncology 2018 1, DOI: ( /j.euo ) Copyright © 2018 European Association of Urology Terms and Conditions
5
Fig. 4 Kaplan-Meier curves for treatment-free survival by Gleason grade at diagnostic biopsy and upgrade during surveillance for the active surveillance cohort at University of California San Francisco. European Urology Oncology 2018 1, DOI: ( /j.euo ) Copyright © 2018 European Association of Urology Terms and Conditions
6
Fig. 5 Kaplan-Meier curves for biochemical recurrence-free survival after deferred radical prostatectomy by Gleason grade 3+3 (n=223 of 325) and 3+4 (n=24 of 42) at diagnostic biopsy for the active surveillance cohort at University of California San Francisco. Patients had two or more postoperative prostate-specific antigen values. European Urology Oncology 2018 1, DOI: ( /j.euo ) Copyright © 2018 European Association of Urology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.